JP TSE 4151 Pharmaceutical

Kyowa Kirin Co.,Ltd.

協和キリン株式会社

Revenue

¥497B

≈ $3.1B

Net income

¥67.0B

≈ $424.4M

Income taxes paid

¥0

≈ $0

Total assets

¥1.11T

≈ $7.0B

Equity ratio

80.6%

Ranked #4,057 among listed Japanese companies by corporate taxes paid · effective tax rate 23.1%.

Share price at fiscal year-end: ¥2,523 · market capitalization ¥1.33T · P/E 19.7 · P/B 1.48

US dollar amounts use ¥158.0 per dollar.

Annual results

Fiscal year	Revenue	Net income	Tax expense	Taxes paid	Total assets	Net assets	Equity ratio	Source
Dec 2025	¥497B	¥67.0B	¥20.2B	¥0	¥1.11T	¥893B	80.6%	EDINET (consol.)
Dec 2024	¥496B	¥59.9B	¥23.6B	¥17.7B	¥1.07T	¥851B	79.7%	EDINET (consol.)
Dec 2023	¥442B	¥81.2B	—	—	¥1.03T	¥836B	81.5%	EDINET (consol.)
Dec 2022	¥398B	¥53.6B	—	—	¥940B	¥763B	81.2%	EDINET (consol.)
Dec 2021	¥352B	¥52.3B	—	—	¥922B	¥737B	80.0%	EDINET (consol.)

From annual securities reports filed with the Financial Services Agency's EDINET. 日本語のページ（同業比較・役員）

Compare with the world's largest companies

See where Japanese companies stand in the world rankings by revenue, profit and taxes paid.